Debates

Monday, 5 December 2011

10:45 - 11:45

Debates 1: Urticaria: Is There a Role for Sedating Antihistamines and Steroids?
Gran Cancún 4 (Cancún Center)
Chairperson: Michael S. Blaiss (US)
10:45 - 10:50
Welcoming Remarks
10:50 - 11:05
1-1DB: Yes | Allen P. Kaplan (US)
11:05 - 11:20
1-2DB: No | Torsten Zuberbier (Germany)
11:20 - 11:25
Yes Rebuttal
11:25 - 11:30
No Rebuttal
11:30 - 11:45
Discussion

15:00 - 16:00

Debates 2: Small Airways: Are They Important in the Pathogenesis of Asthma?
Gran Cancún 3 (Cancún Center)
Chairpersons: Qutayba Hamid (Canada) and Charles Irvin (US)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:20
2-1DB: Pro | Monica Kraft
15:20 - 15:35
2-2DB: Con | Ignacio J. Ansotegui (Spain)
15:35 - 15:40
Pro Rebuttal
15:40 - 15:45
Con Rebuttal
15:45 - 16:00
Discussion
Debates 3: Is the Hygiene Hypothesis Important?
Isla Mujeres (Cancún Center)
Chairpersons: Robert Lemanske, MD (US) and Dale Umetsu, MD, PhD (US)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:20
3-1DB: Pro | Tari Haahtela (Finland)
15:20 - 15:35
3-2DB: Con | Susan L. Prescott (Australia)
15:35 - 15:40
Pro Rebuttal
15:40 - 15:45
Con Rebuttal
15:45 - 16:00
Discussion

Tuesday, 6 December 2011

10:45 - 11:45

Debates 4: Skin Test or In-Vitro Test for Food Allergy?
Gran Cancún 2 (Cancún Center)
Chairpersons: Alvaro Cruz (Brazil) and Rudolf Valenta (Austria)
10:45 - 10:50
Welcoming Remarks
10:50 - 11:05
4-1DB: In-Vitro | Motohiro Ebisawa (Japan)
11:05 - 11:20
4-2DB: Skin Test | Linda Cox (US)
11:20 - 11:25
In-Vitro Rebuttal
11:25 - 11:30
Skin Test Rebuttal
11:30 - 11:45
Discussion
Debates 5: Sublingual Immunotherapy (SLIT) vs Subcutaneous Immunotherapy (SCIT)
Cozumel 1 (Cancún Center)
Chairperson: Enrico Compalati (Italy)
10:45 - 10:50
Welcoming Remarks
10:50 - 11:05
5-1DB: SCIT | Anthony Frew (United Kingdom)
11:05 - 11:20
5-2DB: SLIT | Giovanni Passalacqua (Italy)
11:20 - 11:25
SCIT Rebuttal
11:25 - 11:30
SLIT Rebuttal
11:30 - 11:45
Discussion

15:00 - 16:00

Debates 6: Environmental Control for Allergic Diseases: Does it Work?
Gran Cancún 1 (Cancún Center)
Chairpersons: Juan Carlos Sisul Alvariza (Paraguay) and David Lang (US)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:20
6-1DB: Pro | Thomas Platts-Mills (US)
15:20 - 15:35
6-2DB: Con | Adnan Custovic (United Kingdom)
15:35 - 15:40
Pro Rebuttal
15:40 - 15:45
Con Rebuttal
15:45 - 16:00
Discussion
Debates 7: Atopic Eczema: Barrier Dysfunction or Immune Deviation?
Gran Cancún 3 (Cancún Center)
Chairpersons: Myron Zitt (US) and Tatiana Slavyanskaya (Russia)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:20
7-1DB: Immune Deviation in Atopic Eczema is Crucial | Johannes Ring (Germany)
15:20 - 15:35
15:35 - 15:40
Barrier Dysfunction Rebuttal
15:40 - 15:45
Immune Deviation Rebuttal
15:45 - 16:00
Discussion

Wednesday, 7 December 2011

10:45 - 11:45

Debates 8: Genetically Modified Foods: Are They a Problem?
Costa Maya 1 (Cancún Center)
Chairpersons: Hugh Sampson (US) and Thomas Holzhauser (Germany)
10:45 - 10:50
Welcoming Remarks
10:50 - 11:05
8-1DB: Pro | Dan Atkins (US)
11:05 - 11:20
8-2DB: Con | Amal Assa'ad (US)
11:20 - 11:25
Pro Rebuttal
11:25 - 11:30
Con Rebuttal
11:30 - 11:45
Discussion
Debates 9: Long-Acting Beta Agonists (LABAs) vs. Tiotropium for Asthma
Auditorium (Cancún Center)
Chairpersons: Reynold A. Panettieri, Jr. (US) and Allison Fryer (US)
10:45 - 10:50
Welcoming Remarks
10:50 - 11:05
9-1DB: LABAs | Klaus Rabe (Germany)
11:05 - 11:20
9-2DB: Tiotropium | Mario Castro (US)
11:20 - 11:25
LABAs Rebuttal
11:25 - 11:30
Tiotropium Rebuttal
11:30 - 11:45
Discussion

15:00 - 16:00

Debates 10: Are Basophils Important in Allergy?
Gran Cancún 2 (Cancún Center)
Chairpersons: Francesca Levi-Schaffer (Israel) and Joshua Boyce (US)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:20
10-1DB: Pro | Hirohisa Saito (Japan)
15:20 - 15:35
10-2DB: Con | Massimo Triggiani (Italy)
15:35 - 15:40
Pro Rebuttal
15:40 - 15:45
Con Rebuttal
15:45 - 16:00
Discussion
Debates 11: Are We Ready for Oral Immunotherapy for Food Allergy?
Cozumel 2 (Cancún Center)
Chairpersons: Sami Bahna (US) and Hugh Sampson (US)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:20
11-1DB: Pro | Lyndon Mansfield (US)
15:20 - 15:35
11-2DB: Con | A. Wesley Burks (US)
15:35 - 15:40
Pro Rebuttal
15:40 - 15:45
Con Rebuttal
15:45 - 16:00
Discussion